In this review, we discussed the important role and the possible underlying mechanisms of CB1R in hepatic insulin resistance and metabolic syndrome that will provide clues for the treatment of CB1R-mediated hepatic insulin resistance without causing any adverse effect on the CNS. The gene discussed is CNR1; the disease is Insulin resistance.